Drug:
Reaction: MYELOSUPPRESSION
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26546305 |
CN |
45 | 2 |
Myelosuppression, Decreased appetite, Off label use, |
||||
ABEMACICLIB, |
||||
| 102 | 26536107 |
CN |
65 | 2 |
Myelosuppression, Disease progression, Hypothyroidism, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, |
||||
| 103 | 26536337 |
CN |
42 | |
Myelosuppression, Pyrexia, Hyponatraemia, Diarrhoea, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), TRASTUZUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 104 | 26536724 |
CN |
||
Myelosuppression, Pneumonia, |
||||
POLATUZUMAB VEDOTIN, |
||||
| 105 | 26536954 |
CN |
48 | 2 |
Myelosuppression, |
||||
OSIMERTINIB, CARBOPLATIN, PEMETREXED DISODIUM, |
||||
| 106 | 26537305 |
CN |
42 | 1 |
Product use in unapproved indication, Myelosuppression, Hyponatraemia, Pyrexia, Diarrhoea, Temperature intolerance, Chills, |
||||
TRASTUZUMAB, GEMCITABINE HYDROCHLORIDE, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 107 | 26537773 |
52 | 2 | |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 108 | 26538032 |
85 | 1 | |
Myelosuppression, |
||||
| 109 | 26538045 |
2 | ||
Myelosuppression, |
||||
| 110 | 26538052 |
43 | 2 | |
White blood cell count decreased, Myelosuppression, Platelet count decreased, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 111 | 26538835 |
CN |
28 | 1 |
Myelosuppression, Agranulocytosis, Platelet count decreased, Hepatic function abnormal, Rash erythematous, Pyrexia, |
||||
CYTARABINE, |
||||
| 112 | 26538857 |
CN |
28 | 2 |
Myelosuppression, Rash pustular, Pharyngeal ulceration, Erythema, Off label use, |
||||
METHOTREXATE SODIUM, WATER, STERILE WATER, STERILE WATER FOR INJECTION, |
||||
| 113 | 26539179 |
CN |
70 | 2 |
Myelosuppression, |
||||
OBINUTUZUMAB, OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 114 | 26539220 |
JP |
7 | |
Liver disorder, Renal disorder, Myelosuppression, |
||||
IPILIMUMAB, NIVOLUMAB, |
||||
| 115 | 26539368 |
CN |
38 | 2 |
Myelosuppression, |
||||
OLAPARIB, |
||||
| 116 | 26540221 |
CN |
55 | 1 |
Myelosuppression, Rash, |
||||
LENVATINIB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, |
||||
| 117 | 26540314 |
CN |
51 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 118 | 26540650 |
CN |
71 | 2 |
Myelosuppression, Thrombocytopenia, Hypoaesthesia, |
||||
PRALSETINIB, PRALSETINIB, PRALSETINIB, |
||||
| 119 | 26541136 |
55 | 2 | |
Myelosuppression, Neutrophil count decreased, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 120 | 26541327 |
CN |
59 | 2 |
Myelosuppression, Off label use, |
||||
ABEMACICLIB, ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 121 | 26541332 |
47 | 1 | |
Myelosuppression, |
||||
CETUXIMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 122 | 26541606 |
CN |
55 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 123 | 26541745 |
CN |
68 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, CISPLATIN, CISPLATIN, |
||||
| 124 | 26541812 |
CN |
70 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 125 | 26541834 |
CN |
62 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, PEMETREXED DISODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 126 | 26541851 |
CN |
67 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 127 | 26541867 |
JP |
71 | 1 |
Myelosuppression, Oedema, Infection, |
||||
IVOSIDENIB, IVOSIDENIB, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, FLUCONAZOLE, ITRACONAZOLE, |
||||
| 128 | 26541869 |
CN |
64 | 1 |
Myelosuppression, |
||||
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 129 | 26541872 |
CN |
62 | 2 |
Myelosuppression, |
||||
| 130 | 26531608 |
CN |
7 | 2 |
Myelosuppression, Stomatitis, Pyrexia, Immunosuppressant drug level increased, Off label use, |
||||
RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, DEXAMETHASONE SODIUM PHOSPHATE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE, LEUCOVORIN CALCIUM, |
||||
| 131 | 26531616 |
CN |
37 | |
Myelosuppression, |
||||
GOSERELIN, GOSERELIN, FULVESTRANT, |
||||
| 132 | 26531720 |
CN |
60 | 2 |
Myelosuppression, Off label use, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 133 | 26531864 |
CN |
68 | 1 |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, LEUCOVORIN CALCIUM, |
||||
| 134 | 26532431 |
CN |
41 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
RIBOCICLIB, EXEMESTANE, |
||||
| 135 | 26532487 |
CN |
56 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, VINCRISTINE SULFATE, |
||||
| 136 | 26532522 |
CN |
68 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, CYTARABINE, STERILE WATER FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 137 | 26532808 |
CN |
51 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 138 | 26532865 |
56 | 2 | |
Myelosuppression, |
||||
| 139 | 26532873 |
74 | 2 | |
Myelosuppression, |
||||
| 140 | 26532937 |
49 | 2 | |
Myelosuppression, Blood calcium decreased, Blood potassium decreased, Blood sodium decreased, Blood chloride decreased, Protein total decreased, Blood albumin decreased, |
||||
PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 141 | 26533134 |
CN |
63 | 1 |
Myelosuppression, Pneumonia, Eye haemorrhage, Mouth haemorrhage, Pharyngeal haematoma, Shock haemorrhagic, Respiratory failure, Staphylococcal infection, |
||||
DECITABINE, ETOPOSIDE, CYTARABINE, VENETOCLAX, CYTARABINE, |
||||
| 142 | 26533530 |
CN |
64 | 2 |
Myelosuppression, |
||||
EXEMESTANE, |
||||
| 143 | 26533539 |
CN |
32 | 1 |
Myelosuppression, |
||||
BRENTUXIMAB VEDOTIN, OXALIPLATIN, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 144 | 26533541 |
CN |
49 | 2 |
Myelosuppression, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, ETOPOSIDE, ETOPOSIDE, DACTINOMYCIN, DACTINOMYCIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 145 | 26533745 |
CN |
62 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 146 | 26534014 |
CN |
55 | 2 |
Neutrophil count decreased, White blood cell count decreased, Platelet count decreased, Blood glucose increased, Glycosylated haemoglobin increased, Cough, Productive cough, Bronchitis, Myelosuppression, Breast cancer metastatic, |
||||
INAVOLISIB, PALBOCICLIB, FULVESTRANT, |
||||
| 147 | 26534506 |
CN |
66 | 2 |
Myelosuppression, Pyrexia, |
||||
DURVALUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 148 | 26534646 |
US |
51 | 2 |
Immune-mediated myelitis, Myelosuppression, |
||||
OBECABTAGENE AUTOLEUCEL, |
||||
| 149 | 26534655 |
CN |
59 | 2 |
Myelosuppression, |
||||
| 150 | 26534953 |
CN |
57 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, FULVESTRANT, |
||||
| 151 | 26535187 |
CN |
79 | 1 |
Myelosuppression, Epistaxis, Platelet count decreased, |
||||
PRALSETINIB, |
||||
| 152 | 26535203 |
CN |
53 | 2 |
Myelosuppression, |
||||
| 153 | 26535605 |
AU |
64 | 2 |
Myelosuppression, Radiotherapy, Blood thyroid stimulating hormone decreased, Diarrhoea, Liver function test abnormal, Thyroxine free increased, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PEGFILGRASTIM, CARBOPLATIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PEMBROLIZUMAB, APIXABAN, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 154 | 26535629 |
CN |
78 | 1 |
Myelosuppression, Agranulocytosis, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, |
||||
| 155 | 26535631 |
CN |
51 | 2 |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 156 | 26535656 |
CN |
77 | 1 |
Myelosuppression, Platelet count decreased, |
||||
PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 157 | 26535678 |
CN |
84 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 158 | 26535679 |
CN |
61 | 2 |
Myelosuppression, |
||||
CAPECITABINE, OXALIPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 159 | 26535680 |
CN |
62 | 2 |
Myelosuppression, |
||||
OXALIPLATIN, |
||||
| 160 | 26535697 |
CN |
50 | 2 |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 161 | 26535702 |
CN |
70 | 1 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, |
||||
| 162 | 26535743 |
CN |
75 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 163 | 26526785 |
CN |
79 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 164 | 26526835 |
CN |
66 | 2 |
Myelosuppression, White blood cell count decreased, Platelet count decreased, Monocyte percentage decreased, Lymphocyte count decreased, Monocyte count decreased, Plateletcrit decreased, Neutrophil count decreased, Eosinophil count decreased, Mouth ulceration, Oral pain, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 165 | 26526922 |
CN |
71 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 166 | 26526987 |
CN |
69 | 2 |
Myelosuppression, |
||||
OBINUTUZUMAB, |
||||
| 167 | 26527049 |
CN |
63 | 2 |
Myelosuppression, |
||||
CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 168 | 26527063 |
CN |
71 | 1 |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 169 | 26527136 |
EU |
50 | 2 |
Cardiotoxicity, Cardiogenic shock, Myocardial oedema, Pancytopenia, Myelosuppression, |
||||
| 170 | 26527238 |
CN |
73 | 1 |
Myelosuppression, Nausea, Vomiting, Hiccups, Pyrexia, Cough, Procalcitonin increased, C-reactive protein increased, Bacterial infection, Diarrhoea, Klebsiella infection, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE, PREDNISONE, TICAGRELOR, |
||||
| 171 | 26527290 |
CN |
77 | 2 |
Myelosuppression, Mouth ulceration, |
||||
OSIMERTINIB, |
||||
| 172 | 26528188 |
CN |
66 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, OXALIPLATIN, CAPECITABINE, |
||||
| 173 | 26528242 |
CN |
69 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 174 | 26528612 |
CN |
60 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, STERILE WATER FOR INJECTION, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 175 | 26528624 |
CN |
68 | 2 |
Myelosuppression, |
||||
VENETOCLAX, CYTARABINE, |
||||
| 176 | 26528731 |
CN |
70 | 2 |
Acute respiratory failure, Pneumonia, Myelosuppression, Aspergillus infection, Influenza, Leukopenia, Thrombocytopenia, Product use in unapproved indication, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, POLATUZUMAB VEDOTIN, BENDAMUSTINE HCL, |
||||
| 177 | 26529030 |
CN |
48 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 178 | 26529129 |
CN |
57 | 1 |
Myelosuppression, |
||||
PERTUZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, TRASTUZUMAB, |
||||
| 179 | 26529526 |
CN |
55 | 2 |
Myelosuppression, Hyperpyrexia, Abdominal pain, Chills, |
||||
METHOTREXATE SODIUM, |
||||
| 180 | 26529559 |
CN |
13 | 2 |
Myelosuppression, Anaemia, Ischaemia, Hypoxia, Infection, |
||||
CYTARABINE, |
||||
| 181 | 26529568 |
CN |
9 | 1 |
Myelosuppression, Hyperpyrexia, |
||||
CYTARABINE, CYTARABINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 182 | 26529745 |
JP |
65 | 2 |
Enterococcal bacteraemia, Cytomegalovirus colitis, Myelosuppression, Febrile neutropenia, |
||||
IRINOTECAN HYDROCHLORIDE, CARBOPLATIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METYRAPONE, OSILODROSTAT, OSILODROSTAT, |
||||
| 183 | 26530235 |
CN |
45 | 2 |
Hypersensitivity, Decreased appetite, Alopecia, Diffuse large B-cell lymphoma recurrent, Metastases to bone, Asthenia, Myelosuppression, Death, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, |
||||
| 184 | 26531024 |
CN |
69 | 2 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 185 | 26522572 |
CN |
43 | 2 |
Myelosuppression, White blood cell count decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 186 | 26522597 |
CN |
71 | 1 |
Myelosuppression, |
||||
VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 187 | 26522630 |
CN |
72 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, CAPECITABINE, |
||||
| 188 | 26522691 |
JP |
54 | 1 |
Macular oedema, Diarrhoea, Tinnitus, Deafness neurosensory, Acute kidney injury, Pancytopenia, Febrile neutropenia, Thrombocytopenia, Photophobia, Peripheral sensory neuropathy, Myelosuppression, Vision blurred, Drug-induced liver injury, |
||||
CISPLATIN, CARBOPLATIN, HEPARIN SODIUM, ETOPOSIDE, |
||||
| 189 | 26522993 |
JP |
9 | 2 |
Myelosuppression, Pneumonia, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 190 | 26523055 |
CN |
57 | 2 |
Myelosuppression, |
||||
ADO-TRASTUZUMAB EMTANSINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 191 | 26523194 |
CN |
50 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 192 | 26523268 |
EU |
||
Myelosuppression, Anaemia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, ENZALUTAMIDE, APALUTAMIDE, |
||||
| 193 | 26523277 |
CN |
1 | |
Discomfort, Asthenia, Hypoaesthesia, Decreased appetite, Myelosuppression, Chronic kidney disease, Drug resistance, |
||||
BEVACIZUMAB, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED DISODIUM, LENVATINIB, |
||||
| 194 | 26523336 |
CN |
||
Gastrointestinal disorder, Myelosuppression, Haemorrhage, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, |
||||
| 195 | 26523455 |
CN |
70 | 2 |
Acute respiratory failure, Pneumonia, Aspergillus infection, Influenza, Myelosuppression, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, PREDNISONE, |
||||
| 196 | 26523495 |
CN |
63 | 1 |
Respiratory failure, Shock haemorrhagic, Myelosuppression, Pneumonia, Pyrexia, Haemorrhagic diathesis, Thrombocytopenia, |
||||
CYTARABINE, ETOPOSIDE, |
||||
| 197 | 26523672 |
CN |
37 | 2 |
Myelosuppression, |
||||
FULVESTRANT, FULVESTRANT, GOSERELIN, |
||||
| 198 | 26524112 |
CN |
57 | 2 |
Myelosuppression, Hepatic function abnormal, Depressed mood, Asthenia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 199 | 26524132 |
CN |
72 | 1 |
Dermatitis allergic, Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 200 | 26524472 |
EU |
50 | 2 |
Cardiogenic shock, Pancytopenia, Drug ineffective, Myelosuppression, Thrombocytopenia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, DOBUTAMINE, METHYLPREDNISOLONE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28